title: Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Bearz
authors.forename: Diego
authors.initials: D
authors.lastname: Serraino
authors.forename: Lucia
authors.initials: L
authors.lastname: Fratino
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Berretta
authors.forename: Umberto
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality*; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D016019:Survival Analysis; D015996:Survival Rate / Q000639:trends*
chemical_list: D000970:Antineoplastic Agents